New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
08:06 EDTTHRX, GSKGlaxo, Theravance announce Japanese approval for Anoro Ellipta
GlaxoSmithKline (GSK) and Theravance (THRX) announced Friday that the Japanese Ministry of Health, Labour and Welfare has approved Anoro Ellipta for the relief of various symptoms due to airway obstruction with chronic obstructive pulmonary diseases. Under the terms of the 2002 LABA collaboration agreement, Theravance is obligated to make a milestone payment of $10M to GSK following MHLW approval of UMEC/VI in Japan. Following this approval, it is expected that launch will take place in Japan in Q3, the companies said.
News For GSK;THRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 3, 2015
18:11 EDTGSKSiemens investigated by Chinese regulator last year, Reuters says
Subscribe for More Information
May 1, 2015
07:43 EDTGSKExpensive drugs drove over 25% of 2013 Medicare drug spending, WSJ says
Subscribe for More Information
April 30, 2015
16:59 EDTTHRX, GSKGlaxoSmithKline, Theravance announce FDA approval of Breo Ellipta
Subscribe for More Information
15:20 EDTGSK, THRXGlaxo says FDA issued CRL on use of Breo Ellipta in patients aged 12-17
Subscribe for More Information
15:17 EDTTHRX, GSKGlaxoSmithKline says FDA approves BREO ELLIPTA for adults with asthma
GlaxoSmithKline (GSK) and Theravance (THRX) announced that the FDA has approved BREO ELLIPTA for the once-daily treatment of asthma in patients aged 18 years and older. Breo Ellipta is not indicated for the relief of acute bronchospasm. Breo is a fixed-dose combination of the inhaled corticosteroid fluticasone furoate and the long-acting beta2-agonist vilanterol. Two strengths, 100/25mcg and 200/25mcg, have been approved in the US for use in asthma, administered once-daily using the Ellipta dry powder inhaler.
11:06 EDTTHRXOptions with increasing implied volatility
Subscribe for More Information
07:21 EDTGSK, THRXFDA PDUFA Date for Theravance BREO ELLIPTA is April 30, 2015
April 29, 2015
10:53 EDTTHRXOptions with increasing implied volatility
Options with increasing implied volatility: THRX ALTR ARIA DECK ANF KORS CVC CCE
April 28, 2015
11:04 EDTTHRXOptions with increasing implied volatility
Subscribe for More Information
April 27, 2015
12:28 EDTTHRXOptions with increasing implied volatility
Options with increasing implied volatility: THRX ARRY AKRX DECK HSBC
10:04 EDTGSKHigh option volume stocks
Subscribe for More Information
08:46 EDTGSKAgenus data positive, says JMP Securities
Subscribe for More Information
08:41 EDTGSKTelegraph discusses potential takeover of GSK by Pfizer
Subscribe for More Information
06:19 EDTGSKPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 24, 2015
07:11 EDTGSKAgenus: GSK's RTS,S vaccine showed statistically significant results in study
Subscribe for More Information
April 20, 2015
07:20 EDTGSKAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
07:01 EDTGSKPernix Therapeutics obtains six months U.S. pediatric exclusivity for Treximet
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use